$5.24
-0.52 (-9.03%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+124.6% upside
Low Target
$8.46
Average Target
$11.77
High Target
$14.40
Current Price
$5.24
Current
$5.24
$5.24
Target
$11.77
$11.77
$8.46
$11.77 avg
$14.40
Scenario Analysis
Bear Case
$8.46
61.5%
Low target
Base Case
$11.77
+124.6%
Avg target
Bull Case
$14.40
+174.8%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$23.43
-77.6% from high
52-Week Low
$2.90
+80.7% from low
Target vs 52W High
$11.77
-49.8% vs high
Next Earnings Report
May 28, 2026
10d
until earnings
EPS Est: $-0.90
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |